Showing results (871-880 of 1,047) with videos related to
Sort By:
Pageof 105
The Oncologist|May 10, 2022
Larotrectinib Treatment for Patients With TRK Fusion-Positive Salivary Gland CancersXiuning Le, Christina Baik, Jessica Bauman, et al.JMIR Medical Informatics|July 25, 2023
Interoperable, Domain-Specific Extensions for the German Corona Consensus (GECCO) COVID-19 Research Data Set Using an Interdisciplinary, Consensus-Based Workflow: Data Set Development StudyGregor Lichtner, Thomas Haese, Sally Brose, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 27, 2025
Impact of estimated dose of radiation to immune cells (EDRIC) in locally advanced Non-Small-Cell lung Cancer: A secondary analysis of the multicenter randomized PET-Plan trialCas Stefaan Dejonckheere, Younèss Nour, Jörg Sahlmann, et al.Elife|June 6, 2022
Distinct but overlapping roles of LRRTM1 and LRRTM2 in developing and mature hippocampal circuitsShreya H Dhume, Steven A Connor, Fergil Mills, et al.Lancet (London, England)|April 29, 2014
Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trialMarcia S Brose, Christopher M Nutting, Barbara Jarzab, et al.Cancer Medicine|December 5, 2022
Health-related quality-of-life analyses from a multicenter, randomized, double-blind phase 2 study of patients with differentiated thyroid cancer treated with lenvatinib 18 or 24 mg/dayMatthew H Taylor, Sophie Leboulleux, Yury Panaseykin, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 10, 2019
Larotrectinib in adult patients with solid tumours: a multi-centre, open-label, phase I dose-escalation studyD S Hong, T M Bauer, J J Lee, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2008
A phase I trial of the oral, multikinase inhibitor sorafenib in combination with carboplatin and paclitaxelKeith T Flaherty, Joan Schiller, Lynn M Schuchter, et al.EMBO Molecular Medicine|February 23, 2026
Encephalopathy-linked UFM1 variants impede neuronal protein translation, development, and functionCatarina Perdigão, Josefa Torres, Helge M Magnussen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 14, 2020
Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial CancerVicky Makker, Matthew H Taylor, Carol Aghajanian, et al.Pageof 105